150 related articles for article (PubMed ID: 2978891)
1. Optimization of donor specific blood transfusion in kidney transplantation.
Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
[TBL] [Abstract][Full Text] [Related]
3. Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol.
Salvatierra O; McVicar J; Melzer J; Amend W; Vincenti F; Tomlanovich S; Husing R; Rabkin J; Garovoy M
Transplant Proc; 1991 Feb; 23(1 Pt 2):1024-6. PubMed ID: 1989146
[TBL] [Abstract][Full Text] [Related]
4. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations.
Fujiwara T; Sakagami K; Haisa M; Kusaka S; Uda M; Kobayashi N; Tanakaya K; Saito S; Matsuno T; Matsuoka J
Transplant Proc; 1992 Aug; 24(4):1427-8. PubMed ID: 1386699
[No Abstract] [Full Text] [Related]
6. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
[TBL] [Abstract][Full Text] [Related]
7. Fresh versus stored blood in donor specific transfusion.
Light JA; Metz S; Oddenino K; Simonis T; Strong DM; Reinmuth B; Kumar J; Biggers JA
Transplant Proc; 1982 Jun; 14(2):296-301. PubMed ID: 6214058
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with donor-specific blood transfusions in related recipients with high MLC.
Salvatierra O; Amend W; Vincenti F; Potter D; Iwaki Y; Opelz G; Terasaki P; Duca R; Hanes D; Cochrum KC; Hopper S; Feduska NJ
Transplant Proc; 1981 Mar; 13(1 Pt 1):142-9. PubMed ID: 6455788
[TBL] [Abstract][Full Text] [Related]
9. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
[No Abstract] [Full Text] [Related]
11. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry.
Sonoda T; Ishibashi M
Clin Transpl; 1987; ():257-60. PubMed ID: 2978999
[TBL] [Abstract][Full Text] [Related]
12. Living-unrelated renal transplantation at the University of Wisconsin.
Pirsch JD; D'Alessandro AM; Sollinger HW; Voss BJ; Knechtle SJ; Reed A; Kalayoglu M; Belzer FO
Clin Transpl; 1990; ():241-5. PubMed ID: 2103149
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific blood transfusions versus cyclosporine--the DST story.
Salvatierra O; Melzer J; Vincenti F; Amend WJ; Tomlanovich S; Potter D; Husing R; Garovoy M; Feduska NJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):160-6. PubMed ID: 3547813
[TBL] [Abstract][Full Text] [Related]
14. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
[TBL] [Abstract][Full Text] [Related]
15. Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion.
Cheigh JS; Suthanthiran M; Fotino M; Kaplan M; Evelyn M; Schechter N; Wolf CF; Riggio RR; Riehle R; Stubenbord WT
Uremia Invest; 1985-1986; 9(1):11-7. PubMed ID: 2940741
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
[No Abstract] [Full Text] [Related]
17. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
Anderson CB; Sicard GA; Etheredge EE
Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
[TBL] [Abstract][Full Text] [Related]
19. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine.
Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596
[No Abstract] [Full Text] [Related]
20. Donor-specific transfusion.
Iwaki Y; Terasaki PI
Clin Transpl; 1986; ():267-75. PubMed ID: 3154415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
